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A  novel human  retrovirus,  HTLVcR, was isolated  from a  cutaneous T  cell  lym- 
phoma-derived  cell  line  (1).  A  highly  related  virus,  HTLVI~m,  was  subsequently 
isolated from cells of a patient with cutaneous T  cell leukemia  (2).  The uniqueness of 
these isolates is supported by the lack of relationship of their nucleic acids (3), proteins 
(4),  and  reverse  transcriptase  (5)  to  any  other  type-C  RNA  tumor  virus.  Because 
retroviruses  are  implicated  in  the  cause  of some animal  leukemias  and  lymphomas 
(6), HTLV is of interest as a possible etiologic agent in similar human neoplasias. Our 
descriptions of natural antibodies to internal  HTLV proteins in sera of patients with 
cutaneous T  cell lymphomas and leukemias  (CTCL) 1 strengthens  this possibility  (7, 
8).  To  probe  the  patient  population  for  indications  of HTLV  infection  and  to 
investigate the regulation of viral expression in HTLV-infected cells, we have devel- 
oped monoclonal antibodies to HTLV proteins. We report on a monoclonal antibody 
for HTLV p 19 and on the expression of HTLV p 19 in cells of patients with leukemias 
and lymphomas. 
Materials  and Methods 
Production of Monoclonal Antibody.  Spleen cells  of a  BALB/c mouse hyperimmunized with 
disrupted HTLV were fused with NS-1 myeloma cells (9) using polyethylene glycol 1,000 (10). 
Cells were plated overnight in Dulbecco's modified Eagle medium containing 20% fetal calf 
serum,  10-  M  hypoxanthine,  1.6 ×  10  -s M  thymidine,  1% nonessential amino acids (Gibco 
Laboratories,  Grand  Island  Biological  Co.,  Grand  Island,  N.  Y.),  2  mM  glutamine,  10% 
NCTC109  lymphocyte conditioned  medium  (Microbiological  Associates),  0.5  mM  sodium 
pyruvate, 0.2 U/ml insulin, and  1 mM oxalacetic acid. The cells were transferred to selective 
medium containing, in addition to the above, 4 ×  10  -v M aminopterin and 50 ~g/ml gentamicin 
(Schering Corporation, Kennilworth, N. J.), and were plated into 40 Costar 96-well plates.  5 d 
later, one-half of the medium was changed. Media from hybrid-positive wells were assayed by 
a solid-phase radioimmunoassay (RIA) for antibody to HTLV proteins (7). Positive hybridomas 
were cloned at one cell per 0.2-ml well until two successive clonings gave 100% positive cultures. 
Ascites  fluids were generated  by intraperitoneal  inoculation  of 108 cells  into  BALB/c mice 
primed  1 wk earlier with  1 ml pristane (2,6,10,14-tetramethylpentadecane). 
Metabolic Labeling of Immunoglobulins.  106 cells were washed with Eagle's minimum essential 
i Abbreviations used in this paper:  CTCL, cutaneous T cell lymphomas and leukemias; IdU, iododeoxy- 
uridine; PBS, phosphate-buffered saline; PMSF, pheny[ methyl sulphonyl fluoride; RIA, radioimmunoas- 
say; RIP, radioimmune precipitation; TCGF, T cell growth factor. 
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FIG. 2.  Specificity of hybridoma 12/1-2 antibody. (A) lodinated HTLVcr~ proteins, (~150,000 
epm) were electrophoresed on a 12% polyacrylamide gel (121. The gel was then sliced and counted. 
Molecular weights were calculated with reference to phosphorylase A, bovine serum albumin, 
ovalbumin, chymotrypsinogen,  and ribonuclease  standards. (B) Radioimmune precipitation of ]2~I- 
HTLVca proteins. H, precipitation with 12/1  2 ascites; O  O, precipitation with P3x63 
ascites. (C, D, and E) Gel electrophoresis of ]zSI-HTLVcn  proteins after affinity chromatography on 
12/1-2 IgG-Sepharose. (C) Unbound ]25I-HTLV proteins. (D) Bound 1251-HTLV proteins eluted 
from the affinity column. (E)  Bound 1251-HTLV protein eluted from the affinity column after 
reapplication of the material in (D). 
medium  minus  leucine, supplemented as  the  selective  media,  except  that  hypoxanthine, 
thymidine, and aminopterin  were omitted. Labeling was accomplished by incubation  overnight 
in 200/~1 media containing 1 mCi [z4C]leucine. 
Protein A-Sepharose Chromatography.  2 ml of ascites fluid was processed  on a  7-ml protein A- 
Sepharose (Pharmacia Fine Chemicals, Div. of Pharmacia Inc., Piscataway, N. J.) column (11). 
Antibody binding to HTLV was assayed on 1  : 1,000 dilutions of eluted fractions by the solid- 
phase RIA (7). 
Radioimmune Precipitation (RIP).  Approximately 150,000 cpm ofiodinated HTLVcR proteins 
(7)  in 50 pl  RIP buffer containing 50  mM sodium phosphate,  pH  8.0,  0.3  M  NaCI,  10% 
glycerol,  0.2% Triton X-100, 0.1% gelatin, 0.02% NAN3, and 0.5 mM phenyl methyl sulfonyl 
fluoride (PMSF) were incubated 4-6 h at 4°C with 50 ~1 of a  1:5,000 dilution of ascites fluid. 
250/~1 of a  10% (vol/vol) suspension of protein A-Sepharose in RIP buffer was added. Samples 
were  incubated overnight with mixing and were  centrifuged. Pellets were  washed with  1 ml 
RIP buffer. Immune precipitates were boiled in Laemmli sample buffer (12) and subsequently 
electrophoresed on 12% polyacrylamide gels. 
Affinity  Chromatography.  Hybridoma  12/1-2  IgG1,  purified on  protein A-Sepharose,  was 
coupled to CNBr-Sepharose 4B  (Pharmacia Fine Chemicals). 12SI-HTLVcR proteins in phos- 
phate-buffered saline (PBS) were applied to the column and eluted with 0.2 M  glycine-HC1, 
pH 2.8. The 2-ml fractions were neutralized with I00 #1 2 M Tris-HC1, pH 8.0. The unbound 
and bound proteins were pooled separately, dialyzed against 10 mM NH4HCOz, lyophilized, 
and dissolved in 10 mM sodium phosphate buffer, pH 8.  100-#1 portions of each fraction were 
electrophoresed on 12% polyacrylamide gels (12) that were subsequently sliced and counted. 1960  DETECTION  OF  HUMAN  T  CELL  LYMPHOMA  VIRUS  p19 
TABLE  I 
Specificity of Hybridoma  12/1  2for HTL V-producing  Cells by Immune Fluorescence  Assay 
Immune  Immune 
Cell type  fluorescence  Cell type  fluorescence 
% positive  ~. positive 
HTL V-producing CTCL cells  Transformed CTCL cells not producing HTL V 
H UT 102  + (60- 70)  H UT 78 
HUT102, Clones A9, B2,  +(60-70)  Immature  orpre-TceU hnes 
A 15  Molt-4  -- 
CTCL-3  + ( i 2)  8402 
CR-CTC  +(38)  CCRF-CEM  -- 
CTCL-2  + (5)  CCRF-HSB  -- 
Animal retrovirus infected cells  TALL- 1 
LBv20B/SSAV (N.P.)  --  HPB-MLT 
LBv20A/GaLV (N.P.)  --  HPB-ALL 
NC37/SSV  --  JM 
88/M28  --  PEER  -- 
FEA/FeLVA, FeLVB, or  --  DND-41 
FeLVC  Normal perzpheral blood lymphocytes 
JLSV9/RLV  --  NPBO- 19 
A7573/SSAV  --  NPBO-20 
KHOS (N.P.)  --  NPBO-24 
88/GaLV'rh~i  --  0  49 
B cell lines  0-50  -- 
Daudi  --  0-51  -- 
CCRF-SB  --  0-52 
LBv20E  --  T.O.M.  -- 
NC37  --  NPBI-9  -- 
CR-B cells 
80-81 (EBV) 
80-84 (EBV) 
Indirect  Immune Fluorescence  Assay.  Cells  (3  ×  106) were washed with PBS and suspended in 
200 #1 of a  1:15 dilution of PBS. Aliquots (1-2/~1) were spotted on slides, air dried, and fixed 
for  10 min at  room  temperature in 50% methanol:50% acetone.  Slides were stored at  -20°C 
until use. Ascites of hybridoma  12/1-2 or control ascites of P3x63 cells, diluted  1:400 in PBS, 
was  applied  to  cells  and  incubated  30  min.  The  fluorescein-conjugated  F(ab')2  fragment  of 
sheep anti-mouse IgG (N. L. Cappel Laboratories Inc., Cochranville, Pa.) was purified through 
a human IgG-Sepharose column, diluted, and applied to cells. After 30 rain incubation at room 
temperature, slides were washed for 1-2 h  in PBS before microscopic examination. 
Cells.  The  isolation  of HTLVeR  from  HUT102  cells derived  from  a  patient  (C.R.)  with 
CTCL  has been described  (1), as have CTCL-3  cells derived  from a  second blood sample of 
patient  C.R.  (1).  CR-CTC  cells were  derived  independently from  a  third  blood  sample  of 
patient  C.R.  by Dr.  T.  Waldmann.  Dr.  M.  Maeda  cloned  the  HUT102  cells.  CTCL-2  cells 
derived  from cells of a  patient with cutaneous T  cell leukemia were the source of the second 
HTLV  isolate,  strain  MB  (2).  Other  patient  lymphocytes  were  examined  either as  fresh or 
fresh-frozen cells,  or else were examined after culture in the presence of T  cell growth  factor 
(TCGF)  (13). Normal peripheral blood lymphocytes were cultured using phytohemagglutinin 
and TCGF  (13).  Virus-infected cells included human B  cells infected with but not producing 
woolly monkey (simian sarcoma associated) virus (LBv20B/SSAV); gibbon ape leukemia virus 
(LBv20A/GaLV)  (14); human lymphoblasts infected with simian sarcoma virus (NC37/SSV); 
bat  lung  cells  infected  with  baboon  endogenous  virus  (88/M28);  feline  embryo  fibroblasts 
infected with  strain A,  B,  or C  of feline leukemia  virus  (FEA/FeLVA,  FEA/FeLVB,  FEA/ 
FeLVC);  bat  lung cells  infected  with  GaLV,  Thai  strain  (88/GaLVThai);  mouse  fibroblasts 7
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TABLE II 
Prevalence of HTL V p l9 Expression in Cells of Patients with Leukemias and Lymphomas 
Number  Number  Number  Number 
Cell type  Cell type 
tested  positive  tested  positive 
Cutaneous 7" cell lymphomas  Acute lymphocytic leukemia 
(Mycosis fungoides)  Fresh  7  0 
Fresh  6  0  Fresh frozen  I  0 
Cultured  12  3*  Cult ured  4  0 
Cultured +  ldU  2  0  Cultured +  IdU  1  0 
Cutaneous 7" cell leukemia~  Acute myelocytte leukemia 
(Sezary syndrome)  Cultured  2  0 
FrL.'sh  8  0  Chronic lymphocytic leukemia 
Fresh frozen  2  0  Fresh  3  0 
Cultured  ~  I~  Cultured  I  O 
Cultured +  ldU  I  0  fresh, T  cell type  2  0 
7" cell lymphoma  tlaley cell leukemia 
Fresh  5  0  Fresh  2  O 
Cultured +  IdU  I  0  Cultured  l  0 
Promytlocytic leukemia  Unclassified leukernias 
Cultured  3  0  Fresh  1  O 
Ilodakins  Cultured  3  0 
Cultured  1  0  Cultured +  ldU  t  0 
• The positive ceils include HUTI02 cells, CTC1,-3 cells,and CR-CTC ,:ells. 
:~ The positive cells were CTCI.-2 ceils. 
infected with Rauscher murine leukemia virus (JLSV9/RLV); dog thymus cells infected with 
SSAV (A7573/SSAV);  and human osteogenic sarcoma  cells infected with but not producing 
the Kirsten  rat leukemia virus (KHOS [N.P.]). Among the standard B and T  cell lines used 
were several T cell lines kindly supplied  by Dr. J. Minowada (CCRF-CEM, CCRF-HSB, JM, 
TALL-l, HPB-MLT, HPB-ALL, PEER, and DND-41). CR-B cells refers to B cells of patient 
C.R. The normal B cell lines 80-81 and 80-84 were established in culture after transformation 
with the Epstein-Barr  virus. 
Results and Discussion 
Of several monoclonal antibodies to HTLV, one produced by hybridoma  12/1-2 
has  been  especially useful.  Ouchterlony analysis  and  metabolic labeling  indicated 
that  this hybridoma synthesizes IgG1  with  a  kappa  light chain  (Fig.  1 a  and  b).  A 
confirmation of this  subtype and  evidence that  binding  of 12/I-2  ascites  fluid  to 
HTLV was antibody mediated was obtained by coincident elution of antibody and 
binding activity from a  protein A-Sepharose column at pH 6  (11;  Fig.  1 c). An RIP 
assay  for  HTLV  proteins  illustrated  the  specificity of the  antibody.  Among  the 
iodinated HTLV proteins (Fig. 2 a) only p 19 could be specifically precipitated (Fig. 
2 b).  (The molecular weight of p19 varies with measurement from  16,000  to  19,000.) 
Hybridoma 12/1-2 IgGrSepharose also specifically bound the p19 protein (Fig. 2c, 
d, and e). The column used was too small to quantitatively bind all the p19 (Fig. 2c 
and d).  However, reapplication of the first eluate to the column resulted in specific 
binding of HTLV p19 (Fig.  I e). 
In indirect immune fluorescent assays this anti-pl9 specifically labels only HTLV- 
producing cells (Table I). Transformed HUT78 cells, also derived from a patient with 
CTCL, do not produce HTLV and are negative for p 19. The percentage of fluorescent 
ceils in a positive sample varies. Both HUT102 parental cells and clones are 60-70% 
positive, suggesting that viral expression might be related to cell cycling. CTCL-2 and 
CTCL-3 ceils are 5 and  12% positive, respectively. Presumably, not all the cells are 
producing  virus.  Alternatively,  some cells  might  express  virus  at  levels  too  low  to ROBERT-GUROFF ET AL.  1963 
detect by this assay. In fact, CTCL-2 cells require iododeoxyuridine (IdU) induction 
for significant virus production (2). Normal peripheral blood lymphocytes and human 
T  and B cell lines examined were all negative for the presence of HTLV p19 (Table 
I), emphasizing the viral specificity of the antibody. Anti-pl9 does not recognize cells 
producing other mammalian RNA tumor viruses, which further substantiates the lack 
of relationship of HTLV to these viruses. 
The fluorescent labeling of virus-positive cells is restricted to the cell membrane 
(Fig. 3). Only fixed cells can be labeled, supporting the notion that p19 is an internal 
HTLV protein (4) and not an envelope component. Whereas conventional antisera to 
an  internal  viral  protein  might  stain  the  cytoplasm  of virus-producing ceils,  the 
monoclonal  antibody only recognizes p19  when  the  virus  is  assembled  at  the  cell 
membrane. 
TCGF has enabled growth of malignant  mature T  cells, resulting in isolation of 
HTLV (1, 2).  Two of the HTLV-producing cell lines, HUT102 and CTCL-2 cells, 
now grow independently of exogenous factor. Presumably, TCGF caused stimulation 
of virus production by expansion of the appropriate cell population. We have looked 
for expression of HTLV p 19 in cells of other patients with CTCL as well as of patients 
with other leukemias. Both fresh and cultured cells have been examined. So far, all 
attempts to detect HTLV in this fashion have been negative, including those in which 
we tried to induce HTLV production using IdU  (Table II). It is clear that  HTLV 
p19 is not expressed in most malignant T  cells, indicating that replicating HTLV is 
not  present.  Whether  HTLV  is  present  more  commonly  but  is  not  completely 
expressed, is present only in the early stages of disease, or is present in only a subset 
of T  cell leukemias is not known. The monoclonal antibody to HTLV p19 provides 
an assay for HTLV expression for determining the frequency of HTLV replication in 
human T  cells and for studying the regulation of viral gene expression. 
Summary 
A monoclonal antibody specific for the internal p 19 protein of a type-C retrovirus 
(HTLV) isolated from human  neoplastic T  cells has been developed. Its specificity 
has been shown by radioimmune precipitation and  by affinity chromatography of 
iodinated HTLV proteins. By indirect immune fluorescence this antibody recognizes 
only HTLV-producing cells. Examination of cells from patients with cutaneous T  cell 
lymphomas  and  leukemias  and  with  other  types  of  lymphomas  and  leukemias 
indicated that HTLV p 19 expression is rare. The monoclonal antibody will be useful 
in determining the natural reservoir of HTLV, possibly in a subset of mature T  cell 
neoplasias. 
We thank Dr. John Minna for helpful advice on the techniques of cell fusion. We acknowledge 
the excellent technical assistance of Ms. Emily Anderson. 
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